Necrotizing Enterocolitis: What's New and What's Next?

Area of Science:

• Neonatology
• Pediatric Surgery
• Gastroenterology

Background:

• Necrotizing enterocolitis (NEC) is a major cause of illness and death in premature infants.
• Historical approaches to NEC management have evolved since the 1970s.
• Basic science research is key to understanding NEC pathogenesis.

Purpose of the Study:

• To review research on NEC over the past decade.
• To assess advancements in understanding NEC development and progression.
• To highlight novel biomarkers, therapeutic targets, and clinical trials for NEC.

Main Methods:

• Utilized in vivo (rodents, pigs) and in vitro (cell lines, organoids) NEC models.
• Comprehensive assessment of research literature from the last decade.
• Analysis of clinical trials for novel NEC therapies.

Main Results:

• Innovative models have identified critical NEC biomarkers and pathways.
• Novel therapeutic targets have emerged from basic science research.
• Several potential therapies have advanced to clinical trials.

Conclusions:

• Recent research deepens the understanding of NEC pathogenesis and progression.
• New therapeutic strategies show promise for improving infant outcomes.
• Future research directions aim to further enhance clinical management and quality of life for NEC patients.